Insights & news

Stella Kyriakides Commissioner-Designate for Health

  • 11/09/2019
  • Articles

Stella Kyriakides, a member of the Cypriot parliament, a trained psychologist and a forceful advocate of patient rights (she is a past President of Europa Donna, the breast cancer patient group), has been entrusted with the health portfolio by Ursula von der Leyen, the President-elect of the incoming European Commission. Like the other designated Commissioners, Ms. Kyriakides’ appointment still has to be approved by the European Parliament, but with her colleagues she is expected to take up her position in November 2019.
 
In yesterday’s mission letter to Ms. Kyriakides (see attached), Ms. von der Leyen requests to focus on the following health priorities: 

  •  Supply of affordable medicines – This rubrique covers significant topics such as health technology assessment; the ongoing regulatory review of medicines; and medicine shortages. Ms. von der Leyen specifies that “[Ms. Kyriakides] should support the European pharmaceutical industry to ensure that it remains an innovator and world leader”.
  • E-health and the creation of a European Health Data Space.
  • Implementation of the European One Health Action Plan against Antimicrobial Resistance.
  • Vaccination – The new Commissioner is supposed to communicate persuasively the benefits and necessities of vaccination.
  • Europe’s Beating Cancer Plan – The new Commissioner will be expected to support Member States in improving prevention and care.
  • Medical devices – The new Commissioner is faced with the daunting task of making sure that the recently renewed regulatory framework governing medical devices gets implemented and becomes operational on time. 

These priorities are backed up by administrative changes that will involve the move of key competencies from Directorate General GROW to Directorate General SANTE causing DG SANTE to be put in charge of the full range of pharmaceutical issues as well as medical devices. DG SANTE will also continue to oversee relevant parts of the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) and will carry on managing the relations with a range of other agencies such as the European Medicines Agency.

Attachments:

Key contacts

Related practice areas

Related insights

Sign up for updates
    • 04/06/2020
    • Articles

    Europe - Four-Country Inclusive Vaccine Alliance In Quest for Covid-19 Vaccine

    In a letter to Parliament and a press release (see, attachments), the Dutch Minister for Public Health, Wellbeing and Sports, Hugo de Jonge, revealed on 3 June 2020 an initiative of Italy, France, Germany and The Netherlands to work together to secure a Covid-19 vaccine for “the European Union and other countries”.   According to the Minister, the “Inclusive Vaccine Alliance” (IVA) is in talks with several pharmaceutical companies regarding promising ventures and in the process hopes to establish a European manufacturing base for the vaccine. The IVA’s ultimate goal is to create a medicine that is “accessible, available and affordable”.   Other countries will be given the opportunity to join the IVA which is also in contact with the European Commission.

    Read more
    • 03/06/2020
    • Articles

    European Commission Publishes Roadmap Towards Pharmaceutical Strategy for Europe

    The European Commission (the Commission) published on 2 June 2020 its roadmap towards a Pharmaceutical Strategy for Europe (PSE) which it plans to publish in the fourth quarter of 2020 (see, attachment). The roadmap defines the steps which the Commission will take prior to adopting the PSE and the data which it will assemble to inform its PSE. While the Commission will consult a range of stakeholders, it has already announced a public consultation which will run until 7 July 2020.

    Read more
    • 02/06/2020
    • Articles

    Italian Competition Authority Approves Scheme for Distribution of Surgical Masks

    On 1 June 2020, the Italian competition authority (“L’Autorità Garante della Concorrenza e del Mercato”) authorised a scheme that would allow disposable surgical masks to be distributed and sold in pharmacies and health product retail outlets (see, attached press release). It did so at the request of the two principal Italian associations of pharmaceutical wholesalers. Under the scheme, the wholesalers and associations of pharmacists and health product retailers acquire the masks in a joint procurement procedure. The masks are then allocated among the wholesalers at a uniform price per unit that was agreed upon with the suppliers. The scheme will last until 30 June 2020. The competition authority approved the scheme because it solves an urgent and wide-ranging health problem and is limited in time. It thus applied for the first time the principles of its guidance of 22 April 2020 regarding cooperation agreements designed to ensure the distribution of scarce essential goods and services, including health products and food. The competition authority’s approach is in line with the views expressed by the European Commission and competition authorities around Europe to address the problems resulting from the Covid-19 pandemic (see e.g., Van Bael & Bellis Life Sciences News Alert of 9 April 2020 and of 26 May 2020). Not coincidentally, the competition authority indicates that it obtained counsel from the European Commission.

    Read more

Subscribe to our updates

Please select the practice areas you are interested in: *